아시아 태평양 국소 약물 전달 시장 – 2030년까지의 산업 동향 및 예측

아시아 태평양 국소 약물 전달 시장 분석 및 규모

전 세계적으로 화상 부상 발생률이 증가하는 것은 국소 약물 전달 시장 성장을 증가시키는 주요 요인 중 하나입니다. 경피 제품이 2023-2030년 예측 기간 동안 엄청난 성장률을 보일 것으로 예상됩니다. 여드름과 같은 피부 질환의 유병률이 증가함에 따라 시장이 크게 향상되었습니다. 또한 전 세계적으로 당뇨병이 증가함에 따라 국소 약물 전달에 대한 수요가 급증할 것으로 예상됩니다.

Data Bridge Market Research는 2023-2030년 예측 기간 동안 국소 약물 전달 시장의 성장률을 분석합니다. 국소 약물 전달 시장의 예상 CAGR은 언급된 예측 기간 동안 약 9.4%인 경향이 있습니다. 시장은 2022년에 2억 740만 달러로 평가되었으며, 2030년까지 4억 2,555만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

아시아 태평양 국소 약물 전달 시장 범위 및 세분화

시장 정의

Tropical drug delivery is a type of medication that is applied to specific place usually on body surface or skin or mucous membranes for the treatment of ailments. Drugs applied through these mode of delivery penetrates deep inside the skin and get absorbed more efficiently. These drugs are used for numerous treatments such as fungal, bacterial, viral infections, warts, inflammation, and dermatological conditions. Product such as transdermal drugs provide systematic drug with very little invasiveness.

Asia-Pacific Topical Drug Delivery Market Dynamics

Drivers

• Increasing Rate of Skin Disorders  

The increasing frequency of skin cancer and other associated skin disorders or other skin issues such as acne, vitiligo, and dermatosis combined with the increasing demand of effective drugs are the most prominent factors boosting the growth for this market. Additionally, fungal infection and acne were more incident in the adolescent age group, resulting for around 17.4% and 30.4%, respectively. Asian countries, particularly high-income countries, had a high burden of including acne, alopecia areata, atopic dermatitis, inflammatory dermatoses, contact dermatitis, decubitus ulcers, pruritus, psoriasis, and seborrheic dermatitis. Furthermore, acne prevalence has been reported to be as high as 88% in Asia and can cause a major burden by negatively affecting the quality of life. Thus, this boosts the market growth.   

Opportunities

• Growing Product Launches

The increasing company activities in emerging products and growing product launches are anticipated to boost the market growth. For instance, Nexgel launched MEDAGEL Migraine Relief Patch in November 2021. The patches draw heat away from the body using Nexgel's proprietary hydrogel technology, providing immediate and prolonged cooling relief from migraines, hormonal headaches, and fevers. Furthermore, Luye Pharma Group launched the Rivastigmine Transdermal Patch in China in 2021, for the treatment of mild to moderate Alzheimer's disease. Thus, this factor boost the growth of the market.  

• Increasing Government Funding by Organizations

The growing government funding for increasing the demand and adoption of patches for delivering different vaccines is also contributing to the growth of the segment. For instance, Innoture received funding from the Welsh Government of about GBP 200,000 in July 2020, for its, Self-Administration of SARS-CoV-2 Vaccine via Microlithographic 3D printed Microstructure Patches, project. Such huge developments are estimated to increase the growth of the market.

Restraints/Challenges

• Side-Effects of Drug Delivery Process

Several side-effects are associated with topical drug delivery, such as nausea, dizziness, or headache. Furthermore, irritation, burning, stinging, dryness, or redness at the application site may occur many a times. Thus, these factors restrict the market growth.

This topical drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the topical drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Topical Drug Delivery Market Scope

The topical drug delivery market is segmented on the basis of product, route of administration and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Semi-Solid Formulation
• Liquid Formulation
• Solid Formulation
• Transdermal Products

Route of Administration

• Dermal Drug Delivery
• Opthalmic Drug Delivery
• Rectal Drug Delivery
• Vaginal Drug Delivery
• Nasal Drug Delivery

End User

• Hospitals & Clinics
• Burn Centers
• Research Institutes
• Home Care
• Others

Topical Drug Delivery Market Regional Analysis/Insights

The topical drug delivery market is analyzed and market size insights and trends are provided by product, route of administration and end useras referenced above.

The major countries covered in the topical drug delivery market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China is dominating the market because of increasing number of elderly population combined with the incidence of disease such as diabetes. Several advancement in technology, rising economy, and rise in medical tourism are some of the major factors driving the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Asia-Pacific Topical Drug Delivery Market Share Analysis

국소 약물 전달 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 아시아 태평양 지역 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 국소 약물 전달 시장과 관련된 회사의 초점에만 관련이 있습니다.

국소 약물 전달 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 머크 KGaA(독일)
• Thermo Fisher Scientific(미국)
• 비오메리유(프랑스)
• Agilent Technologies, Inc. (미국)
• BD(미국)
• 바이오툴스 주식회사(미국)
• SGS Société Générale de Surveillance SA(스위스)
• 인터텍 그룹 주식회사(영국)
• Eurofins Scientific(룩셈부르크)
• Mérieux NutriSciences Corporation(프랑스)
• ifp Institut für Produktqualität GmbH (독일)
• 마이크로백 연구소 주식회사(미국)
• FoodChain ID Group, Inc(인도)
• AsureQuality(싱가포르)
• 캠든 BRI(영국)
• ANGLE plc (영국)

SKU-7086